Provided by Tiger Trade Technology Pte. Ltd.

Krystal Biotech Inc.

346.58
+9.562.84%
Post-market: 346.580.00000.00%19:30 EDT
Volume:407.81K
Turnover:140.84M
Market Cap:10.26B
PE:43.51
High:348.03
Open:337.44
Low:335.72
Close:337.02
52wk High:382.54
52wk Low:136.73
Shares:29.60M
Float Shares:23.54M
Volume Ratio:2.19
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.97
EPS(LYR):6.84
ROE:20.12%
ROA:9.37%
PB:7.55
PE(LYR):50.67

Loading ...

S&P Dow Jones Indices Says Krystal Biotech Inc. Will Replace Taylor Morrison Home Corp. in the S&P Midcap 400

THOMSON REUTERS
·
Jul 21

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY), Madrigal Pharmaceuticals (MDGL) and Krystal Biotech (KRYS)

TIPRANKS
·
Jul 14

Krystal Biotech Inc : Bofa Global Research Raises Price Objective to $396 from $364

THOMSON REUTERS
·
Jul 14

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Krystal Biotech (KRYS) and Denali Therapeutics (DNLI)

TIPRANKS
·
Jul 13

Krystal Biotech Stock And 2 Biotech Names With Pipeline Catalysts

Simply Wall St.
·
Jul 13

Krystal Biotech EVP, General Counsel John C. Thomas Disposes of USD 347,270 in Common Shares

Reuters
·
Jun 27

Krystal Biotech (KRYS) Is Up 7.2% After Institutional Ownership Surges To Sector-Leading Levels

Simply Wall St.
·
Jun 23

Krystal Biotech, Inc. : H.c. Wainwright Raises Target Price to $361 From $310

THOMSON REUTERS
·
Jun 16

U.S. RESEARCH ROUNDUP-CAMP4 Therapeutics, Rockwell Automation, Zions Bancorporation

Reuters
·
Jun 16

Krystal Biotech CEO Krish S. Krishnan sells USD 7.77 million in common shares

Reuters
·
Jun 06

A Look At Krystal Biotech (KRYS) Valuation After Vyjuvek Driven Earnings Beat And Pipeline Progress

Simply Wall St.
·
Jun 04

H.C. Wainwright Sticks to Their Buy Rating for Krystal Biotech (KRYS)

TIPRANKS
·
Jun 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM)

TIPRANKS
·
Jun 01

Exploring High Growth Tech Stocks In The US Market May 2026

Simply Wall St.
·
May 28

Krystal Biotech EVP, General Counsel John C. Thomas sells 642 shares for $193,903.26

Reuters
·
May 28

A Look At Krystal Biotech (KRYS) Valuation After UK Approval And Exclusivity Win For VYJUVEK

Simply Wall St.
·
May 25

Krystal Biotech (KRYS) Gets a Buy from Bank of America Securities

TIPRANKS
·
May 22

Corbus Pharma names Nishant Saxena chief business officer

Reuters
·
May 21

Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call

GlobeNewswire
·
May 21

Krystal Biotech shareholders elected Krishnan, Mason as Class III directors

Reuters
·
May 20